CCRCC
Clinical trials for CCRCC explained in plain language.
Never miss a new study
Get alerted when new CCRCC trials appear
Sign up with your email to follow new studies for CCRCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced kidney cancer: first human trial of NEO-811 begins
Disease control Recruiting nowThis early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that has spread or cannot be surgically removed. The goal is to find the safest dose and see how well the drug works. About 30 participants who have already tried other treatme…
Matched conditions: CCRCC
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New radiation therapy targets kidney cancer cells
Disease control Recruiting nowThis phase 3 trial tests a drug called 177Lu-TLX250, which delivers radiation directly to kidney cancer cells. It is for adults with advanced clear cell kidney cancer that has returned or spread after prior treatments. The study first finds the best dose, then compares it to stan…
Matched conditions: CCRCC
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New scan aims to spot hidden kidney cancers without surgery
Diagnosis Recruiting nowThis study tests a special PET/CT scan using a radioactive tracer called 68Ga-NYM096 to see if it can accurately detect clear cell kidney cancer in people with complex kidney cysts who are scheduled for surgery. About 70 participants will receive the tracer and undergo imaging be…
Matched conditions: CCRCC
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC